Trial Profile
Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric Patients With Recurrent Brain Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Benzylguanine; Filgrastim
- Indications Brain cancer
- Focus Adverse reactions
- 08 Aug 2005 New trial record.